We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Shining Light on Farm & Food Policy for 20 Years.
Wednesday, November 27, 2024
In this opinion piece, Ronald B. Phillips of the Animal Health Institute discusses the need for swift reauthorization of the Animal Drug User Fee Act (ADUFA) this Congress.
Food and Drug Administration Commissioner Robert Califf has proposed creating a new Human Foods Program at the agency and has begun a national search for a newly created deputy commissioner for human foods who would report directly to him.
The Food and Drug Administration is calling for a new “regulatory pathway” to allow for the use of use of cannabidiol, or CBD, in dietary supplements and food additives, after concluding that “it is not apparent how CBD products could meet safety standards” for those products.
Frank Yiannas, deputy commissioner for food policy and response at the Food and Drug Administration, announced Wednesday he is stepping down from the agency at the end of February. In his resignation letter, he also called for an empowered deputy commissioner for foods to help better manage food safety oversight at FDA.
The Food and Drug Administration is being closely watched with an anticipated announcement expected January 31 on the direction the agency plans to take following the scathing Reagan-Udall report recommendations on improving FDA’s focus of food. Other work this year for the agency includes finalizing the Food Safety Modernization Act’s agricultural worker rule and reauthorizing the Animal Drug User Fee Act.
Speakers at a recent White House listening session pleaded with the Biden administration to modernize U.S. regulatory oversight of gene-edited plant products to compete with other countries that have streamlined processes allowing for quicker approval.
